On 2026-03-31, NervGen Pharma Corp. (V.NGE) announced earnings per share of -0.11 for the fiscal quarter ending 2025-12-31, missing the average analyst estimate of -0.09.

The next expected annoucement date for quarterly earnings is 2026-06-30, with an average estimated earnings per share of -0.12 for the fiscal quarter ending 2026-03-31.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.